TMT1B
Thiol S-methyltransferase TMT1B
Also known as: ALDI, METTL7B, MGC17301, TMT1B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UX53
- Gene
- TMT1B
- Ensembl
- ENSG00000170439
- Chromosome
- 12
- Canonical length
- 244 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Vesicles,Microtubules
OverviewNCBI Gene
Enables thiol S-methyltransferase activity. Predicted to be involved in methylation. Predicted to be located in cytosol; endoplasmic reticulum membrane; and lipid droplet. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
244 residues, UniProt reviewed canonical sequence.
>Q6UX53|TMT1B
1 MDILVPLLQL LVLLLTLPLH LMALLGCWQP LCKSYFPYLM AVLTPKSNRK MESKKRELFS
61 QIKGLTGASG KVALLELGCG TGANFQFYPP GCRVTCLDPN PHFEKFLTKS MAENRHLQYE
121 RFVVAPGEDM RQLADGSMDV VVCTLVLCSV QSPRKVLQEV RRVLRPGGVL FFWEHVAEPY
181 GSWAFMWQQV FEPTWKHIGD GCCLTRETWK DLENAQFSEI QMERQPPPLK WLPVGPHIMG
241 KAVKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMT1B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 267 nTPM
Expression across tissuesHPA
Tissue
- liver: 267 nTPM
- heart muscle: 136 nTPM
- epididymis: 126 nTPM
- duodenum: 57 nTPM
- small intestine: 53 nTPM
- kidney: 49 nTPM
Single-cell type
- enterocytes: 182 nCPM
- hofbauer cells: 167 nCPM
- epididymal principal cells: 136 nCPM
- hepatocytes: 93 nCPM
- epididymal efferent duct absorptive cells: 86 nCPM
- pituicytes/fscs: 37 nCPM
Immune cell
- myeloid DC: 7 nTPM
- intermediate monocyte: 4.5 nTPM
- non-classical monocyte: 3.3 nTPM
- naive B-cell: 1.7 nTPM
- classical monocyte: 0.8 nTPM
- memory B-cell: 0.5 nTPM
Brain region
- hippocampal formation: 19 nTPM
- thalamus: 17 nTPM
- cerebral cortex: 15 nTPM
- medulla oblongata: 9.4 nTPM
- white matter: 8.3 nTPM
- hypothalamus: 4.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.99
- gnomAD pLI
- 0.07
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMT1B as an antibody target. Whether an autoantibody or antibody against TMT1B could matter depends on whether native TMT1B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMT1B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMT1B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...